Contraception News and Research

Latest Contraception News and Research

Lilly, Merck announce another immuno-oncology collaboration

Lilly, Merck announce another immuno-oncology collaboration

Lilly, Merck expand oncology clinical trial collaboration

Lilly, Merck expand oncology clinical trial collaboration

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

Researchers examine risk of four common types of ovarian cancer in women with different childbearing patterns

Researchers examine risk of four common types of ovarian cancer in women with different childbearing patterns

Impact of physicians' unconscious attitudes toward disabled and LGBT patients

Impact of physicians' unconscious attitudes toward disabled and LGBT patients

Osteopathic physicians, researchers to present clinical and research updates at OMED 15

Osteopathic physicians, researchers to present clinical and research updates at OMED 15

Research shows more than 30,000 women die from cardiovascular disease in UK

Research shows more than 30,000 women die from cardiovascular disease in UK

Johns Hopkins study highlights need for effective postpartum interventions for women with pregnancy complications

Johns Hopkins study highlights need for effective postpartum interventions for women with pregnancy complications

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Report: Birth control pills cause significant increase in stroke risk

Report: Birth control pills cause significant increase in stroke risk

Pregnant teenagers at higher risk of more pregnancies in teenage years

Pregnant teenagers at higher risk of more pregnancies in teenage years

Researchers discover new strategy for attacking cancer cells

Researchers discover new strategy for attacking cancer cells

UVA researchers identify new strategy for attacking cancer cells

UVA researchers identify new strategy for attacking cancer cells

Comprehensive review looks at safety, efficacy of treatment options for premenstrual dysphoric disorder

Comprehensive review looks at safety, efficacy of treatment options for premenstrual dysphoric disorder

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

Women's contraceptive choices often driven by relationships, sexual activity

Women's contraceptive choices often driven by relationships, sexual activity

Abortions performed with Mifepristone result in shorter waiting time, earlier abortions

Abortions performed with Mifepristone result in shorter waiting time, earlier abortions

Out-of-pocket expenses for oral contraceptive pills, IUD decrease since the ACA took effect: Study

Out-of-pocket expenses for oral contraceptive pills, IUD decrease since the ACA took effect: Study

Sociologists to explore ideas, scientific research relating to sexuality at ASA's Annual Meeting

Sociologists to explore ideas, scientific research relating to sexuality at ASA's Annual Meeting

Researchers complete participants’ enrollment in Phase III trial of vaginal ring for HIV prevention

Researchers complete participants’ enrollment in Phase III trial of vaginal ring for HIV prevention

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.